These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23173714)

  • 1. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
    Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
    Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
    Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
    Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I
    Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
    Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J
    Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
    Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2).
    Krassilnikova S; Craig ET; Craig TJ
    Expert Rev Clin Immunol; 2010 May; 6(3):327-34. PubMed ID: 20441418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
    Lumry W; Manning ME; Hurewitz DS; Davis-Lorton M; Fitts D; Kalfus IN; Uknis ME
    J Pediatr; 2013 May; 162(5):1017-22.e1-2. PubMed ID: 23312695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K; Bernstein JA; Machnig T; Craig TJ
    J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
    Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
    Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
    Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
    J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
    Bork K; Staubach-Renz P; Hardt J
    Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
    Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
    BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.